NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 10.80% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 8.80% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 6.60% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 6.06% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 5.72% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.36% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.55% |
| 0QIU | Novo Nordisk A/S Class B | 3.49% | ||
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.44% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 3.36% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.07% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.76% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| CSL | CSL Ltd | Healthcare | Biotechnology | 2.63% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.57% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.41% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.28% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.27% |